Clinical trials
Recruiting Phase 3 Carcinoma, Non-Small-Cell Lung trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
103 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2015 | 1 |
| 2020 | 3 |
| 2021 | 5 |
| 2022 | 8 |
| 2023 | 9 |
| 2024 | 20 |
| 2025 | 36 |
| 2026 | 20 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 103 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Merck Sharp & Dohme LLC | 9 |
| AstraZeneca | 5 |
| Bristol-Myers Squibb | 4 |
| ETOP IBCSG Partners Foundation | 3 |
| National Cancer Institute (NCI) | 3 |
| Pfizer | 3 |
| Akeso | 2 |
| Allist Pharmaceuticals, Inc. | 2 |
| Beijing Pearl Biotechnology Limited Liability Company | 2 |
| Betta Pharmaceuticals Co., Ltd. | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 103 |
| Lung Neoplasms | 17 |
| Carcinoma | 4 |
| Lung Diseases | 3 |
| Neoplasm Metastasis | 3 |
| Neoplasms | 3 |
| Bronchial Neoplasms | 2 |
| Respiratory Tract Neoplasms | 2 |
| Adenocarcinoma | 1 |
| Brain Neoplasms | 1 |
Trials
Showing 1 to 25 of 103. Each trial links to its page on Pharma Observatory.
3 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.